Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
HealthEquity Inc Market Cap
Based on ratings from 14 stock analysts, the HealthEquity Inc stock price is expected to increase by 5.17% in 12 months. This is calculated by using the average 12-month stock price forecast for HealthEquity Inc. The lowest target is $95 and the highest is $130. Please note analyst price targets are not guaranteed and could be missed completely.
HQY is a stock in Healthcare which has been forecasted to be worth $106.78571 as an average. On the higher end, the forecast price is $130 USD by David Larsen from BTIG and on the lower end HQY is forecasted to be $95 by C. Gregory Peters from Raymond James.
These are the latest 20 analyst ratings of HQY.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| David Roman Goldman Sachs | Neutral | $108 | Initiates | Nov 15, 2024 |
| David Larsen BTIG | Buy | $130 | Maintains | Nov 14, 2024 |
| Allen Lutz B of A Securities | Buy | $120 | Maintains | Nov 13, 2024 |
| Alexander Paris Barrington Research | Outperform | $105 | Maintains | Sep 20, 2024 |
Barrington Research | Outperform | Maintains | Sep 5, 2024 | |
| Sean Dodge RBC Capital | Outperform | $92 | Reiterates | Sep 4, 2024 |
| Alexander Paris Barrington Research | Outperform | $105 | Maintains | Sep 4, 2024 |
| George Hill Deutsche Bank | Buy | $103 | Maintains | Sep 4, 2024 |
| Allen Lutz B of A Securities | Buy | $100 | Maintains | Sep 4, 2024 |
| Constantine Davides JMP Securities | Market Outperform | $105 | Reiterates | Sep 4, 2024 |
| Alexander Paris Barrington Research | Outperform | $105 | Maintains | Aug 30, 2024 |
| Allen Lutz B of A Securities | Buy | $105 | Maintains | Jul 3, 2024 |
| Stan Berenshteyn Wells Fargo | Overweight | $110 | Maintains | Jun 20, 2024 |
| C. Gregory Peters Raymond James | Outperform | $105 | Maintains | Jun 7, 2024 |
| Scott Schoenhaus Keybanc | Overweight | $100 | Maintains | Jun 5, 2024 |
| Alexander Paris Barrington Research | Outperform | $105 | Maintains | Jun 4, 2024 |
| Stan Berenshteyn Wells Fargo | Overweight | $107 | Maintains | Jun 4, 2024 |
| Sean Dodge RBC Capital | Outperform | $92 | Reiterates | Jun 4, 2024 |
| Mark Marcon Baird | Outperform | $104 | Maintains | Jun 4, 2024 |
| Constantine Davides JMP Securities | Market Outperform | $105 | Maintains | Jun 4, 2024 |
When did it IPO
2014
Staff Count
3,126
Country
United States
Sector/Industry
Healthcare/Health Information Services
CEO
Mr. Jon Kessler
Market Cap
$9.10B
In 2023, HQY generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that HQY's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 25 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - HealthEquity (HQY) reaches a 52-week high; investors are evaluating the company's fundamentals to assess potential for future gains.
Why It Matters - HealthEquity's 52-week high suggests strong market confidence, while fundamentals will indicate potential for continued growth or risk of a pullback, influencing investment decisions.
Wed, 20 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - HQY's strong performance in Health Savings Accounts (HSAs) is generating positive investor sentiment regarding the stock's potential.
Why It Matters - HQY's strong performance in Health Savings Accounts (HSAs) indicates potential growth and profitability, positively influencing stock sentiment and investor confidence.
Thu, 21 Nov 2024
Sentiment - NEUTRAL
Source - CNBC Television
Summary - Karen Firestone and Steve Weiss discussed their latest portfolio moves on CNBC's 'Halftime Report,' providing insights into their investment strategies.
Why It Matters - Portfolio moves by prominent investors like Firestone and Weiss can signal market trends, influence stock valuations, and impact investor sentiment, potentially affecting investment decisions.
Wed, 20 Nov 2024
Sentiment - POSITIVE
Source - Seeking Alpha
Summary - HealthEquity's growth depends on capital reinvestment, as its asset-light model requires high capital multiples. Its unique core assets support continued attractive operating earnings growth.
Why It Matters - HealthEquity's reliance on capital reinvestment highlights potential volatility in growth and market valuation, influencing investor confidence and stock performance.
Tue, 19 Nov 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Padia received an award for creating innovative, immersive experiences aimed at enhancing client and member engagement.
Why It Matters - Padia's recognition highlights its commitment to enhancing client engagement, potentially driving customer loyalty and revenue growth, which can positively impact its stock performance.
Tue, 19 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - HealthEquity (HQY) experienced significant trading volume recently, but recent earnings estimate revisions may hinder its upward momentum short-term.
Why It Matters - Increased trading volume and negative earnings estimate revisions suggest potential volatility and uncertainty for HealthEquity, impacting investment decisions and stock performance.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
